EKF Diagnostics Holdings (LYF) Ratios
EKF Diagnostics Holdings Ratios
DE:LYF's free cash flow for Q2 2026 was $2.45M. For the 2026 fiscal year, DE:LYF's free cash flow was decreased by $-864.00K and operating cash flow was $3.32M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 4.16 | 4.44 | 2.69 | 2.71 | 3.48 |
| Quick Ratio | 3.04 | 3.29 | 1.77 | 1.90 | 2.51 |
| Cash Ratio | 2.13 | 2.22 | 0.63 | 0.99 | 1.49 |
| Solvency Ratio | 0.69 | 1.29 | 0.62 | -0.23 | 1.07 |
| Operating Cash Flow Ratio | 1.31 | 2.12 | 0.66 | 0.83 | 0.75 |
| Short-Term Operating Cash Flow Coverage | 24.39 | 32.51 | 2.11 | 70.72 | 9.28 |
| Net Current Asset Value | $ 20.01M | $ 20.02M | $ 12.92M | $ 16.99M | $ 27.18M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.02 | 0.02 | 0.05 | 0.02 | 0.03 |
| Debt-to-Equity Ratio | 0.02 | 0.02 | 0.06 | 0.02 | 0.04 |
| Debt-to-Capital Ratio | 0.02 | 0.02 | 0.06 | 0.02 | 0.04 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.18 | 1.13 | 1.20 | 1.22 | 1.22 |
| Debt Service Coverage Ratio | 14.21 | 19.41 | 2.70 | -11.78 | 18.88 |
| Interest Coverage Ratio | 45.31 | 37.77 | 27.75 | 74.16 | 319.81 |
| Debt to Market Cap | 0.00 | 0.00 | 0.02 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.01 | 0.00 | 0.01 |
| Net Debt to EBITDA | -1.17 | -1.16 | -0.25 | 4.60 | -0.62 |
| Profitability Margins | |||||
| Gross Profit Margin | 51.35% | 42.79% | 45.35% | 36.07% | 48.10% |
| EBIT Margin | 13.58% | 12.82% | 4.19% | -13.27% | 26.28% |
| EBITDA Margin | 24.04% | 22.23% | 14.59% | -3.27% | 33.47% |
| Operating Profit Margin | 13.53% | 12.87% | 3.96% | 11.35% | 26.57% |
| Pretax Profit Margin | 13.74% | 12.48% | 4.05% | -13.42% | 26.19% |
| Net Profit Margin | 4.12% | 12.44% | 4.47% | -15.16% | 19.37% |
| Continuous Operations Profit Margin | 4.91% | 13.10% | 5.19% | -14.37% | 19.74% |
| Net Income Per EBT | 29.95% | 99.66% | 110.37% | 112.96% | 73.95% |
| EBT Per EBIT | 101.55% | 96.97% | 102.40% | -118.22% | 98.57% |
| Return on Assets (ROA) | 2.62% | 7.64% | 2.91% | -11.31% | 13.77% |
| Return on Equity (ROE) | 3.07% | 8.63% | 3.50% | -13.77% | 16.84% |
| Return on Capital Employed (ROCE) | 9.47% | 8.58% | 2.92% | 9.75% | 21.43% |
| Return on Invested Capital (ROIC) | 3.36% | 8.48% | 2.78% | 9.63% | 15.85% |
| Return on Tangible Assets | 3.98% | 11.82% | 4.65% | -18.19% | 21.65% |
| Earnings Yield | 1.79% | 5.10% | 1.64% | -4.42% | 4.62% |
| Efficiency Ratios | |||||
| Receivables Turnover | 8.53 | 8.00 | 8.44 | 7.76 | 7.01 |
| Payables Turnover | 33.58 | 31.90 | 29.22 | 28.30 | 9.58 |
| Inventory Turnover | 3.02 | 3.88 | 3.28 | 4.52 | 3.21 |
| Fixed Asset Turnover | 2.31 | 2.09 | 2.12 | 3.07 | 4.58 |
| Asset Turnover | 0.64 | 0.61 | 0.65 | 0.75 | 0.71 |
| Working Capital Turnover Ratio | 2.26 | 2.63 | 2.92 | 2.47 | 2.80 |
| Cash Conversion Cycle | 152.71 | 128.17 | 142.02 | 114.97 | 127.72 |
| Days of Sales Outstanding | 42.78 | 45.64 | 43.23 | 47.03 | 52.07 |
| Days of Inventory Outstanding | 120.80 | 93.98 | 111.28 | 80.84 | 113.77 |
| Days of Payables Outstanding | 10.87 | 11.44 | 12.49 | 12.90 | 38.12 |
| Operating Cycle | 163.58 | 139.61 | 154.51 | 127.86 | 165.84 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.02 | 0.03 | 0.01 | 0.02 | 0.02 |
| Free Cash Flow Per Share | 0.02 | 0.03 | -0.00 | 0.01 | 0.01 |
| Dividend Paid and CapEx Coverage Ratio | 6.34 | 6.08 | 0.51 | 0.86 | 0.95 |
| Capital Expenditure Coverage Ratio | 6.34 | 6.08 | 0.90 | 1.66 | 1.81 |
| Operating Cash Flow Coverage Ratio | 7.01 | 10.36 | 1.54 | 6.26 | 2.95 |
| Operating Cash Flow to Sales Ratio | 0.19 | 0.27 | 0.12 | 0.15 | 0.13 |
| Free Cash Flow Yield | 6.91% | 9.31% | -0.46% | 1.69% | 1.34% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 56.17 | 19.57 | 61.11 | -22.63 | 21.62 |
| Price-to-Sales (P/S) Ratio | 2.30 | 2.44 | 2.73 | 3.43 | 4.19 |
| Price-to-Book (P/B) Ratio | 1.71 | 1.69 | 2.14 | 3.12 | 3.64 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 14.47 | 10.74 | -216.45 | 59.22 | 74.69 |
| Price-to-Operating Cash Flow Ratio | 12.19 | 8.97 | 22.77 | 23.60 | 33.48 |
| Price-to-Earnings Growth (PEG) Ratio | -0.85 | 0.12 | -0.49 | 0.14 | 0.51 |
| Enterprise Value Multiple | 8.38 | 9.82 | 18.47 | -100.16 | 11.90 |
| Enterprise Value | 103.91M | 109.52M | 141.80M | 218.56M | 325.88M |
| EV to EBITDA | 8.38 | 9.82 | 18.47 | -100.16 | 11.90 |
| EV to Sales | 2.02 | 2.18 | 2.70 | 3.28 | 3.98 |
| EV to Free Cash Flow | 12.71 | 9.60 | -213.56 | 56.62 | 71.01 |
| EV to Operating Cash Flow | 10.70 | 8.02 | 22.47 | 22.56 | 31.83 |
| Tangible Book Value Per Share | 0.09 | 0.10 | 0.08 | 0.09 | 0.12 |
| Shareholders’ Equity Per Share | 0.15 | 0.16 | 0.15 | 0.16 | 0.21 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.64 | -0.05 | -0.28 | -0.07 | 0.25 |
| Revenue Per Share | 0.12 | 0.11 | 0.12 | 0.15 | 0.18 |
| Net Income Per Share | 0.00 | 0.01 | 0.01 | -0.02 | 0.03 |
| Tax Burden | 0.30 | 1.00 | 1.10 | 1.13 | 0.74 |
| Interest Burden | 1.01 | 0.97 | 0.97 | 1.01 | 1.00 |
| Research & Development to Revenue | 0.03 | 0.03 | 0.03 | 0.02 | 0.02 |
| SG&A to Revenue | 0.38 | 0.27 | 0.37 | 0.35 | 0.22 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | -0.00 | -0.00 | -0.08 |
| Income Quality | 1.37 | 2.19 | 2.96 | -1.08 | 0.48 |
Currency in GBP